Styrian Vitamin D Hypertension Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT02136771
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT02136771 -
2009-018125-70
-
- Other papers using this trial's data
- Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial
- Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension
- Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial
- Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria
- Registry status
- Completed
Technical summary
Registry record NCT02136771. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2014-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Styrian Vitamin D Hypertension Trial
- Condition
- Arterial Hypertension
- Condition
- Vitamin D Deficiency
- Intervention (Dietary supplement)
- Vitamin D3
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- Medical University of Graz
Record details
- Record id
cardio:ct-nct02136771- Content hash
5c81560c647a75ffc8f3ee71443de54c069473512737bade5a56a2c6cdb45fc2